Terms: = Pancreatic cancer AND CDK6, MGC59692, 1021, Q00534, ENSG00000105810, PLSTIRE
88 results:
1. Depletion of
Yoshizawa M; Shiozaki A; Ashihara E
Cancer Genomics Proteomics; 2024; 21(1):18-29. PubMed ID: 38151292
[TBL] [Abstract] [Full Text] [Related]
2. SETD2 variation correlates with tumor mutational burden and MSI along with improved response to immunotherapy.
Zheng X; Lin J; Xiong J; Guan Y; Lan B; Li Y; Gao X; Fei Z; Chen L; Chen L; Chen L; Chen G; Guo Z; Yi X; Cao W; Ai X; Zhou C; Li X; Zhao J; Yan X; Yu Q; Si L; Chen Y; Chen C
BMC Cancer; 2023 Jul; 23(1):686. PubMed ID: 37479966
[TBL] [Abstract] [Full Text] [Related]
3. Detecting undetectable - epidemiology, etiology, and diagnosis of carcinoma of unknown primary - systematic review.
Ostojewska J; Wieczorek I; Pachciński O; Zdziennicki W; Burdan F
Folia Med Cracov; 2023 Apr; 63(1):19-37. PubMed ID: 37406274
[TBL] [Abstract] [Full Text] [Related]
4. MicroRNA analysis of Natural Killer cell-derived exosomes: the microRNA let-7b-5p is enriched in exosomes and participates in their anti-tumor effects against pancreatic cancer cells.
Di Pace AL; Pelosi A; Fiore PF; Tumino N; Besi F; Quatrini L; Santopolo S; Vacca P; Moretta L
Oncoimmunology; 2023; 12(1):2221081. PubMed ID: 37304055
[TBL] [Abstract] [Full Text] [Related]
5. Tumor-suppressive role of microfibrillar associated protein 4 and its clinical significance as prognostic factor and diagnostic biomarker in hepatocellular carcinoma.
Li J; Wang J; Liu Z; Guo H; Wei X; Wei Q; Zheng S; Xu X
J Cancer Res Ther; 2022 Dec; 18(7):1919-1925. PubMed ID: 36647950
[TBL] [Abstract] [Full Text] [Related]
6. nc-RNA-mediated high expression of cdk6 correlates with poor prognosis and immune infiltration in pancreatic cancer.
Zhao YX; Xu BW; Wang FQ; Jiang FY; Xu JW; Yu DX
Cancer Med; 2023 Feb; 12(4):5110-5123. PubMed ID: 36457244
[TBL] [Abstract] [Full Text] [Related]
7. Combination Therapies with CDK4/6 Inhibitors to Treat KRAS-Mutant pancreatic cancer.
Goodwin CM; Waters AM; Klomp JE; Javaid S; Bryant KL; Stalnecker CA; Drizyte-Miller K; Papke B; Yang R; Amparo AM; Ozkan-Dagliyan I; Baldelli E; Calvert V; Pierobon M; Sorrentino JA; Beelen AP; Bublitz N; Lüthen M; Wood KC; Petricoin EF; Sers C; McRee AJ; Cox AD; Der CJ
Cancer Res; 2023 Jan; 83(1):141-157. PubMed ID: 36346366
[TBL] [Abstract] [Full Text] [Related]
8. Silencing of KNTC1 inhibits hepatocellular carcinoma cells progression via suppressing PI3K/Akt pathway.
Tong H; Liu X; Peng C; Shen B; Zhu Z
Cell Signal; 2023 Jan; 101():110498. PubMed ID: 36273753
[TBL] [Abstract] [Full Text] [Related]
9. The TRPC1 Channel Forms a PI3K/CaM Complex and Regulates pancreatic Ductal Adenocarcinoma Cell Proliferation in a Ca
Schnipper J; Kouba S; Hague F; Girault A; Rybarczyk P; Telliez MS; Guénin S; Tebbakha R; Sevestre H; Ahidouch A; Pedersen SF; Ouadid-Ahidouch H
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887266
[TBL] [Abstract] [Full Text] [Related]
10. Gamma-Glutamyltransferase Activity (GGT) Is a Long-Sought Biomarker of Redox Status in Blood Circulation: A Retrospective Clinical Study of 44 Types of Human Diseases.
Bai C; Zhang M; Zhang Y; He Y; Dou H; Wang Z; Wang Z; Li Z; Zhang L
Oxid Med Cell Longev; 2022; 2022():8494076. PubMed ID: 35707277
[TBL] [Abstract] [Full Text] [Related]
11. LncRNA MAPKAPK5_AS1 facilitates cell proliferation in hepatitis B virus -related hepatocellular carcinoma.
Tao L; Li D; Mu S; Tian G; Yan G
Lab Invest; 2022 May; 102(5):494-504. PubMed ID: 35264707
[TBL] [Abstract] [Full Text] [Related]
12. A non-surgical COMBO-therapy approach for locally advanced unresectable pancreatic adenocarcinoma: preliminary results of a prospective study.
Parisi S; Ferini G; Cacciola A; Lillo S; Tamburella C; Santacaterina A; Bottari A; Brogna A; Ferrantelli G; Pontoriero A; Minutoli F; Pergolizzi S
Radiol Med; 2022 Feb; 127(2):214-219. PubMed ID: 35034325
[TBL] [Abstract] [Full Text] [Related]
13. Inhibition of CK1ε potentiates the therapeutic efficacy of CDK4/6 inhibitor in breast cancer.
Dang F; Nie L; Zhou J; Shimizu K; Chu C; Wu Z; Fassl A; Ke S; Wang Y; Zhang J; Zhang T; Tu Z; Inuzuka H; Sicinski P; Bass AJ; Wei W
Nat Commun; 2021 Sep; 12(1):5386. PubMed ID: 34508104
[TBL] [Abstract] [Full Text] [Related]
14. 18F-FDG PET/CT Imaging Biomarkers for Early and Late Evaluation of Response to First-Line Chemotherapy in Patients with pancreatic Ductal Adenocarcinoma.
Benz MR; Armstrong WR; Ceci F; Polverari G; Donahue TR; Wainberg ZA; Quon A; Auerbach M; Girgis MD; Herrmann K; Czernin J; Calais J
J Nucl Med; 2022 Feb; 63(2):199-204. PubMed ID: 34272317
[TBL] [Abstract] [Full Text] [Related]
15. KDM1A and KDM3A promote tumor growth by upregulating cell cycle-associated genes in pancreatic cancer.
Hou X; Li Q; Yang L; Yang Z; He J; Li Q; Li D
Exp Biol Med (Maywood); 2021 Sep; 246(17):1869-1883. PubMed ID: 34171978
[TBL] [Abstract] [Full Text] [Related]
16. GSG2 knockdown suppresses cholangiocarcinoma progression by regulating cell proliferation, apoptosis and migration.
Zhou J; Nie W; Yuan J; Zhang Z; Mi L; Wang C; Huang R
Oncol Rep; 2021 Jun; 45(6):. PubMed ID: 33846801
[TBL] [Abstract] [Full Text] [Related]
17. A rare germline CDKN2A variant (47T>G; p16-L16R) predisposes carriers to pancreatic cancer by reducing cell cycle inhibition.
Horn IP; Marks DL; Koenig AN; Hogenson TL; Almada LL; Goldstein LE; Romecin Duran PA; Vera R; Vrabel AM; Cui G; Rabe KG; Bamlet WR; Mer G; Sicotte H; Zhang C; Li H; Petersen GM; Fernandez-Zapico ME
J Biol Chem; 2021; 296():100634. PubMed ID: 33823155
[TBL] [Abstract] [Full Text] [Related]
18. Kaempferol suppresses proliferation and induces apoptosis and DNA damage in human gallbladder cancer cells through the CDK4/cdk6/cyclin D1 pathway.
Liu ZQ; Yao GL; Zhai JM; Hu DW; Fan YG
Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1311-1321. PubMed ID: 33629301
[TBL] [Abstract] [Full Text] [Related]
19. Senescence Inflames the pancreatic Tumor Microenvironment.
Petroni G; Galluzzi L
Cell Rep Med; 2020 May; 1(2):100020. PubMed ID: 33205059
[TBL] [Abstract] [Full Text] [Related]
20. The RNA-binding protein MEX3A is a prognostic factor and regulator of resistance to gemcitabine in pancreatic ductal adenocarcinoma.
Panzeri V; Manni I; Capone A; Naro C; Sacconi A; Di Agostino S; de Latouliere L; Montori A; Pilozzi E; Piaggio G; Capurso G; Sette C
Mol Oncol; 2021 Feb; 15(2):579-595. PubMed ID: 33159833
[TBL] [Abstract] [Full Text] [Related]
[Next]